NO164656C - Analogifremgangsmaate for fremstilling av terapeutisk aktivt 1-(4-amionfenyl)-4-methyl-7,8-methylendioxy-3,4-dihydro-5h-2,3-benzodiazepin. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktivt 1-(4-amionfenyl)-4-methyl-7,8-methylendioxy-3,4-dihydro-5h-2,3-benzodiazepin.

Info

Publication number
NO164656C
NO164656C NO873426A NO873426A NO164656C NO 164656 C NO164656 C NO 164656C NO 873426 A NO873426 A NO 873426A NO 873426 A NO873426 A NO 873426A NO 164656 C NO164656 C NO 164656C
Authority
NO
Norway
Prior art keywords
amionphenyl
methylendioxy
benzodiazepine
dihydro
methyl
Prior art date
Application number
NO873426A
Other languages
English (en)
Norwegian (no)
Other versions
NO164656B (no
NO873426L (no
NO873426D0 (no
Inventor
Jeno Koroesi
Tibor Lang
Ferenc Andrasi
Pal Berzsenyi
Peter Botka
Tamas Hamori
Katalin Goldschmidt
Jozsef Borsy
Istvan Elekes
Zsuzsa Lang
Original Assignee
Biogal Gyogyszergyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogal Gyogyszergyar filed Critical Biogal Gyogyszergyar
Publication of NO873426D0 publication Critical patent/NO873426D0/no
Publication of NO873426L publication Critical patent/NO873426L/no
Publication of NO164656B publication Critical patent/NO164656B/no
Publication of NO164656C publication Critical patent/NO164656C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO873426A 1986-08-15 1987-08-14 Analogifremgangsmaate for fremstilling av terapeutisk aktivt 1-(4-amionfenyl)-4-methyl-7,8-methylendioxy-3,4-dihydro-5h-2,3-benzodiazepin. NO164656C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU863594A HU198494B (en) 1986-08-15 1986-08-15 Process for producing new 3,4-dihydro-5h-2,3-benzodiazepine derivative and acid addition salts thereof, as well as pharmaceutical compositions comprising same

Publications (4)

Publication Number Publication Date
NO873426D0 NO873426D0 (no) 1987-08-14
NO873426L NO873426L (no) 1988-02-16
NO164656B NO164656B (no) 1990-07-23
NO164656C true NO164656C (no) 1990-10-31

Family

ID=10964707

Family Applications (1)

Application Number Title Priority Date Filing Date
NO873426A NO164656C (no) 1986-08-15 1987-08-14 Analogifremgangsmaate for fremstilling av terapeutisk aktivt 1-(4-amionfenyl)-4-methyl-7,8-methylendioxy-3,4-dihydro-5h-2,3-benzodiazepin.

Country Status (23)

Country Link
US (1) US4835152A (de)
JP (1) JPS6399073A (de)
AT (1) ATA202187A (de)
AU (1) AU596206B2 (de)
BE (1) BE1002415A4 (de)
CA (1) CA1284322C (de)
CH (1) CH673652A5 (de)
CS (1) CS264150B2 (de)
DD (1) DD265627A5 (de)
DE (1) DE3727226A1 (de)
DK (1) DK164555C (de)
ES (1) ES2004985A6 (de)
FI (1) FI85706C (de)
FR (1) FR2602773B1 (de)
GB (1) GB2194236B (de)
HU (1) HU198494B (de)
IT (1) IT1222508B (de)
NL (1) NL8701909A (de)
NO (1) NO164656C (de)
PL (1) PL148535B1 (de)
RU (1) RU1779251C (de)
SE (1) SE467357B (de)
YU (1) YU46223B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU219778B (hu) * 1990-12-21 2001-07-30 Gyógyszerkutató Intézet Közös Vállalat Eljárás N-acil-2,3-benzodiazepin-származékok, savaddíciós sóik és az ezeket tartalmazó gyógyászati készítmények előállítására, valamint a vegyületek egy csoportja, és az ezeket tartalmazó gyógyászati készítmények
US5639751A (en) * 1990-12-21 1997-06-17 Cyogyszerkutato Intezet Kft N-acyl-2,3-benzodiazepine derivatives for treating acute and chronic neurodegenerative disorders
HU206719B (en) * 1990-12-21 1992-12-28 Gyogyszerkutato Intezet Process for producing 1-/4-acylamino-phenyl/-7,8-methylenedioxy-5h-2,3-benzodiazepine derivatives, acid addicional salts and pharmaceutical compositions containing them
TR199501071A2 (tr) 1994-08-31 1996-06-21 Lilly Co Eli Dihidro-2,3-benzodiazepin türevlerinin üretilmesi icin stereoselektif islem.
US6288057B1 (en) * 1994-08-31 2001-09-11 Eli Lilly And Company Physical form of dihydro-2,3-benzodiazepine derivative
US5891871A (en) * 1996-03-21 1999-04-06 Cocensys, Inc. Substituted 2,3-benzodiazepin-4-ones and the use thereof
UA67749C2 (uk) * 1997-08-12 2004-07-15 Егіш Дьйодьсердьяр Рт. Похідна 8-заміщеного-9н-1,3-діоксол/4,5-h//2,3/бензодіазепіну з властивостями амра/каїнатного антагоніста, спосіб одержання похідних, фармацевтична композиція (варіанти), спосіб її одержання та спосіб лікування
US6649607B2 (en) * 2001-05-18 2003-11-18 Vela Pharmaceuticals, Inc. Compositions and methods for treating or preventing convulsions or seizures
US6864251B2 (en) * 2002-12-03 2005-03-08 Vela Pharmaceuticals, Inc. Treatment of LTB4-mediated inflammatory disorders with optically-pure (R)-2,3-benzodiazepines
AU2003293405A1 (en) * 2002-12-03 2004-06-23 Vela Pharmaceuticals, Inc. Pharmaceutical composition of 1-(3,4-dimethoxyphenyl)-4-methyl-5-ethyl-7-methoxy-8-hydroxy-5h-2,3-benzodiazepine and uses thereof
US6638928B1 (en) 2002-12-03 2003-10-28 Vela Pharmaceuticals, Inc. Treatment of irritable bowel syndrome and nonulcer dyspepsia with substituted 2,3-benzodiazepines
AU2003303312A1 (en) * 2002-12-03 2004-08-30 Vela Pharmaceuticals, Inc. Pharmaceutical composition of 1-(3-hydroxy-4-methoxyphenyl)-4-methyl-5-ethyl-7,8-dimethoxy-5h-2,3-benzodiazepine and uses therof
US7022700B2 (en) * 2002-12-03 2006-04-04 Vela Pharmaceuticals, Inc. Method of increasing neutrophil production using optically-pure (R)-2,3-benzodiazepines
US20040162284A1 (en) * 2003-02-19 2004-08-19 Harris Herbert W. Method of lowering body temperature with (S) tofisopam
US20040224943A1 (en) * 2003-02-19 2004-11-11 Leventer Steven M. Method of lowering body temperature with (R) - 2,3-benzodiazepines
EP1624875A4 (de) * 2003-05-16 2010-01-20 Vela Acquisition Corp Behandlung von gastrointestinaler dysfunktion und verwandten belastungen mit einem enantiomerisch reinen (r) 2,3-benzodiazepin
US20070021412A1 (en) * 2003-05-16 2007-01-25 Vela Pharmaceuticals, Inc. Treatment of gastrointestinal dysfunction and related stress with an enantiomerically-pure (S) 2,3-benzodiazepine
US20040254173A1 (en) * 2003-06-13 2004-12-16 Leventer Steven M. Modulation of dopamine responses with substituted (S)-2,3-benzodiazepines
US20050096464A1 (en) * 2003-10-30 2005-05-05 Heikki Heikkila Separation process
EP4197536A1 (de) * 2021-12-20 2023-06-21 Universitat de València Haloperidol zur behandlung von spinaler muskelatrophie

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU186760B (en) * 1981-03-12 1985-09-30 Gyogyszerkutato Intezet Process for preparing 3,4-dihydro-5h-2,3-aenzodiazepine derivatives
DE3319491A1 (de) * 1982-06-19 1983-10-13 Alps Electric Co., Ltd., Tokyo Papierfuehrungsmechanismus fuer schreibgeraete
HU191698B (en) * 1984-07-27 1987-03-30 Gyogyszerkutato Intezet Process for producing new 1-aryl-5h-2beta-benzodiazepines

Also Published As

Publication number Publication date
HUT47287A (en) 1989-02-28
SE467357B (sv) 1992-07-06
DK424887A (da) 1988-02-16
YU151487A (en) 1988-12-31
AU7688087A (en) 1988-02-18
DK164555C (da) 1992-11-30
GB2194236B (en) 1990-03-21
US4835152A (en) 1989-05-30
CH673652A5 (de) 1990-03-30
AU596206B2 (en) 1990-04-26
DE3727226A1 (de) 1988-02-18
RU1779251C (ru) 1992-11-30
FI873525A0 (fi) 1987-08-14
DK424887D0 (da) 1987-08-14
FR2602773A1 (fr) 1988-02-19
BE1002415A4 (fr) 1991-02-05
CA1284322C (en) 1991-05-21
FR2602773B1 (fr) 1990-11-02
JPS6399073A (ja) 1988-04-30
NO164656B (no) 1990-07-23
SE8703169L (sv) 1988-02-16
GB2194236A (en) 1988-03-02
IT8721667A0 (it) 1987-08-14
CS600787A2 (en) 1988-08-16
FI85706B (fi) 1992-02-14
NO873426L (no) 1988-02-16
HU198494B (en) 1989-10-30
GB8719265D0 (en) 1987-09-23
IT1222508B (it) 1990-09-05
DD265627A5 (de) 1989-03-08
NO873426D0 (no) 1987-08-14
ATA202187A (de) 1993-06-15
PL148535B1 (en) 1989-10-31
DK164555B (da) 1992-07-13
NL8701909A (nl) 1988-03-01
FI85706C (fi) 1992-05-25
FI873525A (fi) 1988-02-16
CS264150B2 (en) 1989-06-13
SE8703169D0 (sv) 1987-08-14
YU46223B (sh) 1993-05-28
ES2004985A6 (es) 1989-02-16

Similar Documents

Publication Publication Date Title
NO164656C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt 1-(4-amionfenyl)-4-methyl-7,8-methylendioxy-3,4-dihydro-5h-2,3-benzodiazepin.
NO162115C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5h-2,3-benzodiazepinderivater.
NO166639C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte, basiske 2-aminotetraliner.
NO904694D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater.
NO901684D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater.
NO903088D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive diazepin-derivater.
NO880182L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,2-dihydro-3h-indazol-3-on-derivater.
NO902411D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-n-propylaminer.
NO884638L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetraliner, kromaner og beslektede forbindelser.
NO863671L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-2-heterocykloalkylpyrido(4,3)indoler.
FI91964C (fi) Menetelmä uusien, farmaseuttisesti aktiivisten 1-(hydroksistyryyli)-5H-2,3-bentsodiatsepiinijohdannaisten valmistamiseksi
NO873108D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-benzodiazepiner.
NO884176D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive amidinoderivater.
NO881768L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner.
NO891046D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,2,4-triazol-derivater.
NO166642C (no) Anaolgifremgangsmaate for fremstilling av terapeutisk aktive 3-aryl-5-alkylthio-4h-1,2,4-triazoler.
NO882281D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
NO891025L (no) Fremgangsmaate for fremstilling av nye, terapeutisk aktivesialosylglycerider.
NO900972L (no) Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater.
NO894516D0 (no) Fremgangsmaate for fremstilling av 1-aminoalkyl-3-oksosubstituert-4-aryl-1,3,4,5-tetrahydro-2h-1,3-benzodiazepin-2-on, og deres anvendelse som medikamenter.
NO900942D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive azacyklooktadien-derivater.
NO904470D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzodiazepinderivater.
NO882282L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
NO883959D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenolestere.
NO883932D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive laktamderivater.